by Team Small News | Oct 11, 2025 | Pharma, Zydus
The Appellate Authority for Advance Ruling (AAAR) in Ahmedabad, Gujarat, has upheld a ruling by the Gujarat Authority for Advance Ruling (GAAR) that subscription and redemption of mutual fund units constitute a sale transaction, subject to input tax credit (ITC)...
by Team Small News | Oct 7, 2025 | Pharma, Zydus
Zydus, a leading Indian pharmaceutical company, has received approval from the US Food and Drug Administration (USFDA) for a new drug. This approval is a significant milestone for the company, as it demonstrates its ability to develop and manufacture high-quality...
by Team Small News | Oct 5, 2025 | Glenmark, Pharma, Torrent Pharma, Zydus
The Indian Pharmaceutical Alliance (IPA) has announced a new leadership team, with Sharvil Patel, Managing Director of Zydus Lifesciences, taking over as President. Patel succeeds Samir Mehta, Chairman of the Torrent Group, and will be joined by Glenn Saldanha,...
by Team Small News | Oct 3, 2025 | Cipla, Pharma, Sun Pharma, Zydus
Zydus Lifesciences’ Managing Director, Dr. Sharvil Patel, has taken over as the new President of the Indian Pharmaceutical Alliance (IPA). The IPA is a coalition of Indian pharmaceutical companies that aims to promote the interests of the domestic pharmaceutical...
by Team Small News | Oct 3, 2025 | Pharma, Zydus
The US Food and Drug Administration (FDA) has rejected the New Drug Application (NDA) for CUTX-101, a treatment for Menkes disease, developed by Fortress Biotech and Zydus Technologies. The FDA’s decision was based on concerns regarding Good Manufacturing...
by Team Small News | Sep 29, 2025 | Aurobindo Pharma, Pharma, Sun Pharma, Zydus
Sun Pharma, Zydus, and three other pharmaceutical companies have issued recalls for their products in the US market. The recalls were initiated due to various reasons, including contamination, labeling issues, and deviations from manufacturing standards. Sun Pharma,...